title: Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients.
authors.affiliation: Department of Biochemistry, Nantes University Hospital, France.
authors.forename: Audrey
authors.initials: A
authors.lastname: Vallée
authors.forename: Marie
authors.initials: M
authors.lastname: Marcq
authors.forename: Acya
authors.initials: A
authors.lastname: Bizieux
authors.forename: Claude El
authors.initials: CE
authors.lastname: Kouri
authors.forename: Hervé
authors.initials: H
authors.lastname: Lacroix
authors.forename: Jaafar
authors.initials: J
authors.lastname: Bennouna
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Douillard
authors.forename: Marc G
authors.initials: MG
authors.lastname: Denis
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D009154:Mutation; D020135:Peptide Nucleic Acids / Q000235:genetics*; D016066:Pleural Effusion, Malignant / Q000235:genetics*
chemical_list: D020135:Peptide Nucleic Acids; D066246:ErbB Receptors